PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Agnelli, Giancarlo
TI  - Apixaban is an Effective Replacement for Conventional Anticoagulation Therapy
DP  - 2013 Sep 01
TA  - MD Conference Express
PG  - 11--12
VI  - 13
IP  - 13
4099  - http://mdc.sagepub.com/content/13/13/11.short
4100  - http://mdc.sagepub.com/content/13/13/11.full
AB  - Apixaban, an oral factor Xa inhibitor, is noninferior to enoxaparin plus warfarin for the treatment of acute symptomatic proximal deep vein thrombosis and pulmonary embolism, and is associated with significantly less bleeding compared with conventional therapy. Administered in fixed doses, apixaban may simplify the treatment of acute venous thromboembolism. This article presents the results of the Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism [AMPLIFY; NCT00643201].